Ardelyx Q3 revenue $98.2M; IBSRELA $40.6M, XPHOZAH $51.5M; net loss $0.8M

ARDELYX, INC.

2024-Q3 EPS reported -$0.19 revenue$217,486,000

IBSRELA Q3 net sales $40.6M (+15% QoQ); full-year guidance set at $145-150M.
XPHOZAH Q3 net sales $51.5M (+39% QoQ); strong launch continues.
Total revenue $98.2M (up 74% YoY); net loss $0.8M vs net income $6.6M in Q3 2023.
Cash $190.4M at Sep 30; drew $49.7M from SLR loan (SOFR+4.02%) in October.
Appointed Eric Foster as CCO in August; CMS Part D change for XPHOZAH cited as 2025 headwind.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.